谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Real World Outcomes in Patients with Recurrent, Advanced or Metastatic Endometrial Cancer Treated with Lenvatinib Plus Pembrolizumab

A. Pawsey, P. Mahalingam, N. Senthivel, A. Ramessur, E. Turnbull, S. Usman, R. Browne, A. Patel, A. Stewart,L. Tookman,N. Counsell,R. Miller,S. Nicum,G. Eminowicz

CLINICAL ONCOLOGY（2025）

引用 0|浏览6
关键词
Endometrial cancer,Lenvatinib,Pembrolizumab,Tolerability,Toxicity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要